Tekla Healthcare Opportunities Fund
Location
Massachusetts
Founded
2014-01-26
Website
Risk Signals
235 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Trusts, Except Educational, Religious, and Charitable), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Tekla Healthcare Opportunities Fund
Live alerts from global media, monitored by Business Radar
2023-10-13 (tmcnet.com)
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
Read more2023-10-13 (tmcnet.com)
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more2023-06-20 (yahoo.com)
Tekla Capital Management LLC Announces Proposed Transaction
BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1
Read more